Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer-related
death and has an extremely poor prognosis. Thus, identifying new disease-associated …

Pancreatic ductal adenocarcinoma (PDAC) is one of the most complicated and fatally
pathogenic human malignancies. Therefore, there is an urgent need to improve our …

Pancreatic ductal adenocarcinoma (PDAC) is a malignant tumor with a high degree of
malignancy that is difficult to diagnose and treat. The present study integrated PDAC cohort …

Introduction The prognosis of patients with pancreatic ductal adenocarcinoma (PDAC) is
highly variable and there is a paucity of effective treatment options for patients with PDAC …

Background Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest solid tumors.
The rapid progression of PDAC results in an advanced stage of patients when diagnosed …

Background Although the pancreatic ductal adenocarcinoma (PDAC) presents high mortality
and metastatic potential, there is a lack of effective therapies and a low survival rate for this …

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal forms of cancer, and its
etiology remains largely unknown. This study aimed to screen a panel of key genes and to …

Pancreatic ductal adenocarcinoma (PAAD) is one of the most common malignant tumors in
digestive system. To find the new therapeutic targets and explore potential mechanisms …

Purpose Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy. Up
till now, the patient's prognosis remains poor which, among others, is due to the paucity of …

This study aimed to explore the underlying genes and pathways associated with pancreatic
ductal adenocarcinoma (PDAC) by bioinformatics analyses. Gene expression profile …